Indications for Recombinant Human Growth Hormone and Evaluation of Available Recombinant Human Growth Hormone Devices: Implications for Managed Care OrganizationsByJeffrey D. Dunn, PharmD, MBA,Nancy A. Nickman, PhDMay 8th 2012
Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care EnvironmentByMay 8th 2012
Participating Faculty: Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care EnvironmentByMay 7th 2012
Clinical and Humanistic Aspects of Growth Hormone Deficiency and Growth-Related DisordersByAlan D. Rogol, MD, PhDMay 7th 2012
Issues Related to Recombinant Human Growth Hormone Utilization and Optimization in a Health Plan SettingByNancy A. Nickman, PhD,Jeffrey D. Dunn, PharmD, MBAMay 7th 2012
